Joost H.M. van Delft

3.7k citations
96 papers · 2.7k indexed · h-index 33
Topics
Carcinogens and Genotoxicity Assessment (45 papers)Gene expression and cancer classification (13 papers)Pharmacogenetics and Drug Metabolism (11 papers)

In The Last Decade

Joost H.M. van Delft

95 papers receiving 2.6k citations

Peers

Joost H.M. van Delft
Comparison fields: 5 of 120
  • Molecular Biology 1.3k
  • Cancer Research 1.0k
  • Health, Toxicology and Mutagenesis 638
  • Pharmacology 321
  • Plant Science 255
Replace Jiri Aubrecht with:
Jiri Aubrecht United States
Lois D. Lehman‐McKeeman United States
Thomas L. Goldsworthy United States
Jay I. Goodman United States
Atsushi Ono Japan
Wolfram Parzefall Austria
Charlene A. McQueen United States
Georges de Sousa France
R. Bars France
Gary M. Williams United States
Joost H.M. van Delft relative to Jiri Aubrecht United States Jiri Aubrecht's profile →
Citations per field
00.5×1.7×
Jiri Aubrecht · 1×
Citations per year

Countries citing papers authored by Joost H.M. van Delft

Since Specialization
Citations

This map shows the geographic impact of Joost H.M. van Delft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joost H.M. van Delft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joost H.M. van Delft more than expected).

Fields of papers citing papers by Joost H.M. van Delft

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joost H.M. van Delft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joost H.M. van Delft. The network helps show where Joost H.M. van Delft may publish in the future.

Co-authorship network of co-authors of Joost H.M. van Delft

This figure shows the co-authorship network connecting the top 25 collaborators of Joost H.M. van Delft. A scholar is included among the top collaborators of Joost H.M. van Delft based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joost H.M. van Delft. Joost H.M. van Delft is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 5
2 26
3 38
4 36
5 56
6 26
7 42
8 7
9 57
10 31
11 25
12 14
13 2
14 70
15 5
16 10
17 14
18 10
19 9
20 10

About Joost H.M. van Delft

Joost H.M. van Delft is a scholar working on Cancer Research, Pharmacology and Chemical Health and Safety, having authored 96 papers that have together received 2.7k indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (45 papers), Gene expression and cancer classification (13 papers) and Pharmacogenetics and Drug Metabolism (11 papers). The work is most often cited by research in Cancer Research (1.0k citations), Health, Toxicology and Mutagenesis (638 citations) and Pharmacology (321 citations). Joost H.M. van Delft has collaborated with scholars based in Netherlands, United Kingdom and Belgium. Frequent co-authors include Jos Kleinjans, Marcel H. M. van Herwijnen, Danyel Jennen, Robert A. Baan, Ralph W.H. Gottschalk, Christina Magkoufopoulou, Yvonne C.M. Staal, Karen Brauers, Hans B. Ketelslegers and Sandra M.H. Claessen. Their work appears in journals such as Nucleic Acids Research, Journal of Molecular Biology and Environmental Health Perspectives.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026